Use of Identical INN “Imiglucerase” for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database

INTRODUCTION: Approved in 1994 and assigned the International Nonproprietary Name (INN) imiglucerase by the World Health Organization, Cerezyme(®) (Sanofi Genzyme) is an enzyme replacement therapy used to treat Gaucher disease in > 90 countries. At least two therapies approved outside the USA and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, So-Fai, Pandya, Shirali, Barakov, Kristina, Keutzer, Joan, Lewis, Grace, Ross, Leorah, Freisens, Selena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857131/
https://www.ncbi.nlm.nih.gov/pubmed/35020177
http://dx.doi.org/10.1007/s40264-021-01125-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857131/
https://www.ncbi.nlm.nih.gov/pubmed/35020177
http://dx.doi.org/10.1007/s40264-021-01125-4

Ejemplares similares